APA (7th ed.) Citation

Racaniello, G. F., Balenzano, G., Arduino, I., Iacobazzi, R. M., Lopalco, A., Lopedota, A. A., . . . Denora, N. (2024). Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy. Pharmaceutics, 16(2), 277. https://doi.org/10.3390/pharmaceutics16020277

Chicago Style (17th ed.) Citation

Racaniello, Giuseppe Francesco, Gennaro Balenzano, Ilaria Arduino, Rosa Maria Iacobazzi, Antonio Lopalco, Angela Assunta Lopedota, Hakon Hrafn Sigurdsson, and Nunzio Denora. "Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy." Pharmaceutics 16, no. 2 (2024): 277. https://doi.org/10.3390/pharmaceutics16020277.

MLA (9th ed.) Citation

Racaniello, Giuseppe Francesco, et al. "Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy." Pharmaceutics, vol. 16, no. 2, 2024, p. 277, https://doi.org/10.3390/pharmaceutics16020277.